News | October 29, 2010

Automated Anastomosis Systems Enable Endoscopic CABG

October 29, 2010 – An automated anastomosis system to minimize operating time and enable minimally-invasive and robot-assisted coronary artery bypass graft (CABG) surgery is being featured today in several demonstrations and wet lab presentations at the Advances in Robotic and Hybrid Coronary Revascularization conference. The meeting was jointly developed by the International College of Robotic Surgery and Saint Joseph's Hospital in Atlanta.

The Cardica Inc. C-Port Flex-A Anastomosis System and its PAS-Port Proximal Anastomosis System are being featured in procedures for beating heart totally endoscopic coronary artery bypass (BH TECAB).

"This inaugural meeting will host more than 100 cardiothoracic surgeons from around the world, and is the first of its kind," said Bernard A. Hausen, M.D., Ph.D., president and CEO of Cardica. "We congratulate the presenting surgeons, who continue to push the envelope and remain on the leading edge of cardiothoracic surgery, and commend the cardiothoracic surgeons and specialists attending the meeting, who are advancing their capabilities in minimally invasive cardiothoracic surgery. This forum represents an ideal interchange to advance the field of less invasive cardiac surgery."

To view a presentation showing Husam Balkhy, M.D., completing a BH TECAB, visit www.cardica.com/presentations/bhtecab/player.html. Cardica's C-Port Distal Anastomosis and PAS-Port Proximal Anastomosis Systems automate the connection of blood vessels (known as anastomoses) during CABG surgery, replacing hand-sewn sutures.

The reliable, automated connection of the vessels is particularly useful for accessing difficult to reach targets. Anastomoses are often considered the most critical step of the bypass procedure. Cardica's PAS-Port proximal system attaches the bypass graft to the aorta, upstream of the occlusion, while Cardica's C-Port Distal Anastomosis Systems connect the bypass grafts to coronary arteries downstream of the occlusion. A triple bypass procedure, for example, requires up to five anastomoses. In many instances, all connections could be performed using Cardica's PAS-Port and C-Port anastomosis systems. Cardica is a co-sponsor of the conference.

For more information: www.cardica.com

Related Content

SherpaPak Cardiac Transport System Cleared for Pediatric and Small Donor Hearts
Technology | Cardiovascular Surgery | February 01, 2019
Paragonix Technologies Inc. recently received clearance from the U.S. Food and Drug Administration (FDA) for a design...
Transplanting Pig Hearts Into Humans One Step Closer. A pig heart, shown here, is very similar in size and anatomy to a human heart. For this reason, pigs are used extensively in pre-clinical animal testing for new implantable cardiovascular devices. If pig hearts could be used for human transplantation, it would greatly alleviate shortages of donor human hearts.

A pig heart, shown here, is very similar in size and anatomy to a human heart. For this reason, pigs are used extensively in pre-clinical animal testing for new implantable cardiovascular devices. If pig hearts could be used for human transplantation, it would greatly alleviate shortages of donor human hearts.

News | Cardiovascular Surgery | December 11, 2018
The scientific journal Nature recently published an article from Munich University Hospital which describes the long-...
Bilateral Artery Use Does Not Improve 10-Year CABG Outcomes
News | Cardiovascular Surgery | September 06, 2018
While it is firmly established that the use of one internal thoracic artery can improve life expectancy in coronary...
Mandatory Public Coronary Artery Bypass Grafting Reporting Associated With Better Patient Outcomes
News | Cardiovascular Surgery | April 30, 2018
Mandatory public reporting of coronary artery bypass grafting (CABG) results in Massachusetts was associated with...
Gecko Biomedical Receives CE Mark Approval for Setalum Sealant
News | Cardiovascular Surgery | September 19, 2017
Gecko Biomedical announced it has received CE Mark approval for its Setalum Sealant, allowing the company to market its...
ClearFlow Inc. Announces Positive U.S. Clinical Trial Results
News | Cardiovascular Surgery | September 08, 2017
September 8, 2017 — ClearFlow Inc.
Videos | Cardiovascular Surgery | July 19, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
Intensive Glycemic Control Program Produces Significant Per-Patient Cost Savings for CABG Surgery
News | Cardiovascular Surgery | May 25, 2017
A new study from Emory University observed a near-20 percent reduction in perioperative complications, a 1.2-day...
Risk of Heart Transplant Rejection Reduced by Desensitizing Patient Antibodies
News | Cardiovascular Surgery | May 23, 2017
The risk of heart transplant rejection can be reduced by desensitizing patient antibodies, according to research...
Overlay Init